FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108403897> ?p ?o ?g. }

• W2108403897 endingPage "1373" @default.
• W2108403897 startingPage "1367" @default.
• W2108403897 abstract "In this study, we report the clinical outcomes of 7 children with bladder/prostate rhabdomyosarcoma (RMS) treated with proton radiation and compare proton treatment plans with matched intensity-modulated radiation therapy (IMRT) plans, with an emphasis on dose savings to reproductive and skeletal structures.Follow-up consisted of scheduled clinic appointments at our institution or direct communication with the treating physicians for referred patients. Each proton radiotherapy plan used for treatment was directly compared to an IMRT plan generated for the study. Clinical target volumes and normal tissue volumes were held constant to facilitate dosimetric comparisons. Each plan was optimized for target coverage and normal tissue sparing.Seven male patients were treated with proton radiotherapy for bladder/prostate RMS at the Massachusetts General Hospital between 2002 and 2008. Median age at treatment was 30 months (11-70 months). Median follow-up was 27 months (10-90 months). Four patients underwent a gross total resection prior to radiation, and all patients received concurrent chemotherapy. Radiation doses ranged from 36 cobalt Gray equivalent (CGE) to 50.4 CGE. Five of 7 patients were without evidence of disease and with intact bladders at study completion. Target volume dosimetry was equivalent between the two modalities for all 7 patients. Proton radiotherapy led to a significant decrease in mean organ dose to the bladder (25.1 CGE vs. 33.2 Gy; p=0.03), testes (0.0 CGE vs. 0.6 Gy; p=0.016), femoral heads (1.6 CGE vs. 10.6 Gy; p=0.016), growth plates (21.7 CGE vs. 32.4 Gy; p=0.016), and pelvic bones (8.8 CGE vs. 13.5 Gy; p=0.016) compared to IMRT.This study provides evidence of significant dose savings to normal structures with proton radiotherapy compared to IMRT and is well tolerated in this patient population. The long-term impact of these reduced doses can be tested in future studies incorporating extended follow-up, objective outcome measures, and quality-of-life analyses." @default.
• W2108403897 created "2016-06-24" @default.
• W2108403897 creator A5014884181 @default.
• W2108403897 creator A5032479678 @default.
• W2108403897 creator A5040519062 @default.
• W2108403897 creator A5056658906 @default.
• W2108403897 creator A5059779868 @default.
• W2108403897 creator A5065893978 @default.
• W2108403897 creator A5071602502 @default.
• W2108403897 creator A5072375420 @default.
• W2108403897 creator A5082178994 @default.
• W2108403897 date "2011-12-01" @default.
• W2108403897 modified "2023-09-30" @default.
• W2108403897 title "Proton Radiotherapy for Pediatric Bladder/Prostate Rhabdomyosarcoma: Clinical Outcomes and Dosimetry Compared to Intensity-Modulated Radiation Therapy" @default.
• W2108403897 cites W1693048258 @default.
• W2108403897 cites W1967269334 @default.
• W2108403897 cites W1971396345 @default.
• W2108403897 cites W1976079788 @default.
• W2108403897 cites W1982343420 @default.
• W2108403897 cites W1983805637 @default.
• W2108403897 cites W1985006583 @default.
• W2108403897 cites W1985438597 @default.
• W2108403897 cites W1988966440 @default.
• W2108403897 cites W2008700492 @default.
• W2108403897 cites W2011249157 @default.
• W2108403897 cites W2012218138 @default.
• W2108403897 cites W2018037742 @default.
• W2108403897 cites W2027042743 @default.
• W2108403897 cites W2032968239 @default.
• W2108403897 cites W2040145532 @default.
• W2108403897 cites W2052106489 @default.
• W2108403897 cites W2052857879 @default.
• W2108403897 cites W2053400643 @default.
• W2108403897 cites W2055844668 @default.
• W2108403897 cites W2058757582 @default.
• W2108403897 cites W2072087143 @default.
• W2108403897 cites W2074268245 @default.
• W2108403897 cites W2107307464 @default.
• W2108403897 cites W2117120112 @default.
• W2108403897 cites W2118628520 @default.
• W2108403897 cites W2144906623 @default.
• W2108403897 cites W2147860910 @default.
• W2108403897 cites W2151994366 @default.
• W2108403897 cites W2160997009 @default.
• W2108403897 cites W2267126688 @default.
• W2108403897 doi "https://doi.org/10.1016/j.ijrobp.2010.07.1989" @default.
• W2108403897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20934266" @default.
• W2108403897 hasPublicationYear "2011" @default.
• W2108403897 type Work @default.
• W2108403897 sameAs 2108403897 @default.
• W2108403897 citedByCount "86" @default.
• W2108403897 countsByYear W21084038972012 @default.
• W2108403897 countsByYear W21084038972013 @default.
• W2108403897 countsByYear W21084038972014 @default.
• W2108403897 countsByYear W21084038972015 @default.
• W2108403897 countsByYear W21084038972016 @default.
• W2108403897 countsByYear W21084038972017 @default.
• W2108403897 countsByYear W21084038972018 @default.
• W2108403897 countsByYear W21084038972019 @default.
• W2108403897 countsByYear W21084038972020 @default.
• W2108403897 countsByYear W21084038972021 @default.
• W2108403897 countsByYear W21084038972022 @default.
• W2108403897 countsByYear W21084038972023 @default.
• W2108403897 crossrefType "journal-article" @default.
• W2108403897 hasAuthorship W2108403897A5014884181 @default.
• W2108403897 hasAuthorship W2108403897A5032479678 @default.
• W2108403897 hasAuthorship W2108403897A5040519062 @default.
• W2108403897 hasAuthorship W2108403897A5056658906 @default.
• W2108403897 hasAuthorship W2108403897A5059779868 @default.
• W2108403897 hasAuthorship W2108403897A5065893978 @default.
• W2108403897 hasAuthorship W2108403897A5071602502 @default.
• W2108403897 hasAuthorship W2108403897A5072375420 @default.
• W2108403897 hasAuthorship W2108403897A5082178994 @default.
• W2108403897 hasConcept C121608353 @default.
• W2108403897 hasConcept C126322002 @default.
• W2108403897 hasConcept C126838900 @default.
• W2108403897 hasConcept C142724271 @default.
• W2108403897 hasConcept C201645570 @default.
• W2108403897 hasConcept C2776235491 @default.
• W2108403897 hasConcept C2778256501 @default.
• W2108403897 hasConcept C2779244869 @default.
• W2108403897 hasConcept C2780844630 @default.
• W2108403897 hasConcept C2989005 @default.
• W2108403897 hasConcept C509974204 @default.
• W2108403897 hasConcept C71924100 @default.
• W2108403897 hasConcept C75088862 @default.
• W2108403897 hasConceptScore W2108403897C121608353 @default.
• W2108403897 hasConceptScore W2108403897C126322002 @default.
• W2108403897 hasConceptScore W2108403897C126838900 @default.
• W2108403897 hasConceptScore W2108403897C142724271 @default.
• W2108403897 hasConceptScore W2108403897C201645570 @default.
• W2108403897 hasConceptScore W2108403897C2776235491 @default.
• W2108403897 hasConceptScore W2108403897C2778256501 @default.
• W2108403897 hasConceptScore W2108403897C2779244869 @default.
• W2108403897 hasConceptScore W2108403897C2780844630 @default.
• W2108403897 hasConceptScore W2108403897C2989005 @default.
• W2108403897 hasConceptScore W2108403897C509974204 @default.
• W2108403897 hasConceptScore W2108403897C71924100 @default.

• next